METHOD FOR EVALUATING THERAPEUTIC EFFICIENCY OF ENDOCRINE OPHTHALMOPATHY Russian patent published in 2006 - IPC A61B8/06 A61B8/14 

FIELD: medicine, ophthalmology.

SUBSTANCE: before the onset of therapy, on the 10^th - 14^th d, 1 mo after therapy and then according to values it is necessary to carry out complex ultrasound orbital investigation that includes B-scanning, the study of circulation in orbital vessels due to energetic and chromatic Doppler mapping of orbital artery and the upper orbital vein. Before therapy one should detect the following dysfunctions: edema of retrobulbar fiber, increased length of retrobulbar area being above 15 mm, thickness of orbital muscles being above 5.5 mm, muscular coefficient being above 60%, thickness of optic nerve being above 4.5 mm, increased maximal systolic rate of circulation up to 45 cm/sec, systolo-diastolic rate being above 5.5, values of hemodynamic ratio indices - resistance one being above 0.75 and pulsation index being above 1.5 of orbital artery, decreased linear rate of circulation in orbital vein being below 5.8 cm/sec. If during repeated trials one can observe decreased edema of retrobulbar fiber, decreased thickness of orbital muscles and other above-mentioned parameters one should state upon positive dynamics after efficient therapy conducted. The innovation enables to perform monitoring of therapy flow and evaluating therapeutic efficiency in case of endocrine ophthalmopathy due to applying complex echography - B-scanning and testing alterations of orbital vascular hemodynamics with techniques of chromatic and energetic Doppler mapping.

EFFECT: higher accuracy of evaluation.